Anzeige
Mehr »
Mittwoch, 20.05.2026 - Börsentäglich über 12.000 News
Bewertet mit 8$ - Preis:139$: Peer-Übernahmen brachten Anlegern dreistellige Gewinne
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 932242 | ISIN: IE0005711209 | Ticker-Symbol: IJF
Tradegate
20.05.26 | 13:06
97,50 Euro
-0,41 % -0,40
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ICON PLC Chart 1 Jahr
5-Tage-Chart
ICON PLC 5-Tage-Chart
RealtimeGeldBriefZeit
97,0498,0618:42
97,0498,0618:42

Aktuelle News zur ICON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13.05.Icon Expands Early Phase Capabilities4
ICON Aktie jetzt für 0€ handeln
13.05.ICON plc: ICON expands US early phase research capabilities with new clinic and outpatient centres322New, 69.5K square-foot, state-of-the-art clinic in Texas integrates clinical, laboratory, and pharmacy infrastructure all under one roof Two new satellite outpatient clinics in Texas and...
► Artikel lesen
29.04.ICON plc: ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results569ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company's...
► Artikel lesen
29.04.ICON PLC - 6-K, Report of foreign issuer3
26.03.BMO upgrades ICON stock rating on pharma backdrop improvement19
26.03.Verbessertes Pharma-Umfeld: BMO Kapital stuft ICON-Aktie auf "Outperform" hoch14
24.03.ICON, Advarra Partner on Connected Site Network Model6
24.03.ICON plc: ICON and Advarra Introduce New 'Research-Ready,' Connected Site Network Model497Partnership will integrate ICON's clinical trial technology with Advarra's purpose-built system for research sites, embedded across a broad, deeply established global network. Partnership...
► Artikel lesen
24.02.Here is Why ICON Public Limited Company (ICLR) Offers an Impressive Upside28
23.02.ClearBridge Global Value Improvers Strategy adds BEP and MKKGY; exits PYPL and ICLR37
18.02.Levi & Korsinsky, LLP: ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement411(NASDAQ: ICLR) NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating ICON plc (NASDAQ: ICLR) following the company's disclosure on February...
► Artikel lesen
14.02.ICON Public Limited Company (ICLR) Delays Earnings Amid Internal Investigation13
12.02.Clinical Research Provider Icon Stock Crashes On Accounting Probe65
12.02.ICON PLC - 6-K, Report of foreign issuer24
27.01.ICON Opens New Cancer Institute in Illinois5
27.01.ICON plc: ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership510ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly...
► Artikel lesen
07.01.ICON PLC - 6-K, Report of foreign issuer4
05.01.Artisan Mid Cap Value Fund Increased its Stake in ICON Public Limited Company (ICLR). Here's Why13
17.12.25Here's Why ICON Plc. (ICLR) Gained +20.3% in Q39
09.12.25ICON plc: ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive574ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update...
► Artikel lesen
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1